Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

143
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
143

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Challenging Weight-Tiered Antibiotic Prophylaxis in Obese Patients Undergoing Colorectal Surgery Using CT-Derived Body Composition.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

The effects of neoadjuvant chemoradiotherapy-related frailty by analytic morphomics in esophageal cancer.

Journal of cardiothoracic surgery·2026
Same author

Name MASLD/MASH - and act on it.

JHEP reports : innovation in hepatology·2026
Same author

Practice changing RCT design and rationale: Abbreviated MRI plus AFP <i>vs.</i> ultrasound plus AFP for HCC surveillance in cirrhosis (PREMIUM study).

JHEP reports : innovation in hepatology·2026
Same author

Name MASLD/MASH - and act on it.

Annals of hepatology·2026
Same author

Name MASLD/MASH - and act on it.

Hepatology communications·2026
Same journal

Reviewer Recognition.

Clinical and translational gastroenterology·2026
Same journal

Cost effectiveness of modalities of Palliative Biliary Drainage in Malignant Extrahepatic Biliary Obstruction.

Clinical and translational gastroenterology·2026
Same journal

Beyond the Count: Critical Gaps in Intraepithelial Lymphocyte-Based Progression Markers of Potential Autoimmune Gastritis.

Clinical and translational gastroenterology·2026
Same journal

Short-term mortality is reduced and low grade ACLF reversed by TIPS in patients with fluid overload: a case-control study.

Clinical and translational gastroenterology·2026
Same journal

Response to Jamalinia and Lonardo.

Clinical and translational gastroenterology·2026
Same journal

The impact of obesity on inflammatory cytokines and 90- and 180-day survival in patients with alcohol-associated hepatitis.

Clinical and translational gastroenterology·2026
See all related articles

Related Experiment Video

Updated: Jul 23, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

Using Artificial Intelligence to Predict Cirrhosis From Computed Tomography Scans.

Nikhilesh R Mazumder1,2, Binu Enchakalody3, Peng Zhang3

  • 1Gastroenterology Section, VA Ann Arbor Healthcare System, Ann Arbor, Michigan, USA.

Clinical and Translational Gastroenterology
|July 12, 2023
PubMed
Summary
This summary is machine-generated.

An automated tool using CT scans and patient data can predict cirrhosis, improving detection for both pre- and post-transplant patients. This aids in diagnosing liver disease more effectively.

More Related Videos

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
06:09

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Published on: July 21, 2023

1.2K
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.2K

Related Experiment Videos

Last Updated: Jul 23, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
06:09

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Published on: July 21, 2023

1.2K
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.2K

Area of Science:

  • Radiology and Medical Imaging
  • Hepatology
  • Artificial Intelligence in Medicine

Background:

  • Undiagnosed cirrhosis is a significant clinical challenge.
  • Accurate prediction of cirrhosis is crucial for patient management and treatment.
  • Existing diagnostic methods may have limitations in certain patient populations.

Purpose of the Study:

  • To develop and validate an automated liver segmentation tool for cirrhosis prediction.
  • To assess the performance of imaging features extracted from CT scans.
  • To evaluate the combination of imaging features with clinical data for improved diagnostic accuracy.

Main Methods:

  • Trained an automated liver segmentation model (3D-U-Net, DeeplLabv3+) on 1,590 CT scans.
  • Extracted imaging features from an external cohort of 351 patients with paired CT and liver biopsy data.
  • Developed multivariate models using gradient boosting decision trees to predict histologic cirrhosis.
  • Evaluated model performance using 5-fold cross-validation and area under the receiving operating characteristic (aUC).

Main Results:

  • The combination of liver morphomics with laboratory and demographic data achieved an aUC of 0.85 (0.81-0.90).
  • This combined model significantly outperformed FIB-4 alone (aUC 0.76) (P < 0.001).
  • Liver morphomics alone showed comparable performance to FIB-4 (aUC 0.71 vs 0.76).

Conclusions:

  • Automatically extracted CT features combined with electronic medical record data improve cirrhosis prediction.
  • This tool shows potential for detecting undiagnosed cirrhosis in both pre- and post-transplant patients.
  • This proof-of-principle study highlights a promising approach for liver disease management.